Food and Drug Administration (FDA) has endorsed the designation Breakthrough Therapy to AXS-05. As announced, the drug product will treat the major depressive disorder (MDD).
For half a century, the science behind antidepressants has not advanced. But, do you know depression patients have new hope? Discoveries in depression news will change everything. This includes anesthetic ketamine.
What’s The Hope in Depression News?
Major depressive disorder (MDD) leads to causing disability in the world. Mood disorder affects about 300 million people globally. Unfortunately, the traditional treatments discovered in the 1960s and 70s failed many patients.
One out of three patients didn’t receive medication benefits. Meanwhile, one out of five MDD patients suffers from treatment-resistant depression. Check this guide to learn about the newest breakthroughs in depression treatment.[Read more…]